WEPURE develops and manufactures silica and resin microspheres and chromatography separation media.
Established in 2022, WEPURE is based in Guangzhou, China. It makes silica- and resin-based nano- and micron-sized microspheres and chromatography products for biomedical research, analysis, testing, separation and purification. In August 2024, it raised Series A funding from Greatwall Fund, DJ Asset Management and Jingtao Capital. In January 2026, it raised Series B funding from Guangdong Technology Financial Group and Greatwall Fund to support R&D, capacity and market development.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in